JPRN-jRCT2080221451未知1 期
Phase I Clinical Study of RG7167 in Patients with Advanced Solid Tumors
试验速览
- 阶段
- 1 期
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Histologically or cytologically confirmed solid tumor
- •-Advanced cancer that did not respond to the standard therapy or for which a standard therapy has not been established
- •-PS of 0 to 2
排除标准
- •-Patients in whom an adverse reaction to the previous treatment persists at Grade 2 or higher
- •-Patients with metastasis to the central nervous system that is accompanied by symptoms or requires treatment
- •-Clinically significant inflammatory condition is observed on the ocular surface
- •-Patients who have been treated with a drug targeting MEK in the past
研究者
相似试验
未知
1 期
Phase I Clinical Study of RG7304 in Patients with Advanced Solid TumorsJPRN-jRCT2080221452Chugai Pharmaceutical Co., Ltd.30
进行中（未招募）
3 期
Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC), Unresponsive to Bacillus-Calmette-Guerin (BCG)on Muscular Invasive Bladder CancerJPRN-jRCT2043210017Shimizu Yoshitaka110
招募中
1 期
Phase I study of RO7187797 in patients with Multiple myeloma.Multiple myelomaJPRN-jRCT2061220045anki Toshihiro6
已完成
1 期
Phase I&IIa trial of KW-0761 in patients with HAMHTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)JPRN-UMIN000012655St. Marianna University School of Medicine Hospital33
已完成
1 期
Phase I/II study of NS-87 in patients with high risk acute myeloid leukemia.Acute myeloid leukemiaJPRN-jRCT2080224810ippon Shinyaku Co., Ltd.41